Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...
Ascletis reports positive topline results from US phase I study of ASC50, a potential best-in-class oral small molecule IL-17 inhibitor: Hong Kong Tuesday, December 16, 2025, 14:3 ...
Winter is the best season to refresh your skin. Learn why cold weather and softer sunlight make treatments safer and more ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) ...
India Today on MSN
Think dandruff is from poor hygiene? Here's what the dermatologist says
Dandruff can be persistent, and it’s not always due to poor hygiene. Dermatologist Dr. BL Jangid explains the main reasons it keeps returning and how to fix it.
Worthy of Skincare brings you a minimalist three step routine for glowing calm skin. It can be used to treat bruises, eczema, ...
Arya Vaidya Sala Kottakkal launches 11 modern Ayurvedic wellness and personal care products, tapping India’s fast-growing ...
Discover effective strategies to protect your hair and skin from the damaging effects of hard water in urban areas.
Appoints accomplished commercial leader Chris Martin to its Board of DirectorsMENLO PARK, Calif., Dec. 11, 2025 (GLOBE ...
The microbiome not only consists of bacteria, but also of fungi. Most of them support human and animal health. However, some ...
BofA raised Johnson & Johnson's price target to $220, citing steady growth, but sees limited upside from its pipeline through ...
Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback